Koninklijke Philips (NYSE:PHG – Get Free Report) is scheduled to be announcing its earnings results before the market opens on Monday, April 29th. Individual interested in listening to the company’s earnings conference call can do so using this link.
Koninklijke Philips (NYSE:PHG – Get Free Report) last issued its quarterly earnings data on Monday, January 29th. The technology company reported $0.44 earnings per share for the quarter, beating analysts’ consensus estimates of $0.41 by $0.03. The company had revenue of $5.45 billion for the quarter, compared to the consensus estimate of $5.47 billion. Koninklijke Philips had a negative net margin of 2.53% and a positive return on equity of 14.17%. On average, analysts expect Koninklijke Philips to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.
Koninklijke Philips Stock Up 1.7 %
Shares of Koninklijke Philips stock opened at $21.07 on Friday. The company has a market cap of $19.57 billion, a price-to-earnings ratio of -36.96, a price-to-earnings-growth ratio of 1.09 and a beta of 0.88. The company’s 50 day moving average is $20.43 and its 200 day moving average is $20.91. Koninklijke Philips has a twelve month low of $17.75 and a twelve month high of $24.27. The company has a quick ratio of 0.78, a current ratio of 1.20 and a debt-to-equity ratio of 0.58.
Analyst Upgrades and Downgrades
View Our Latest Report on Koninklijke Philips
About Koninklijke Philips
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Featured Articles
- Five stocks we like better than Koninklijke Philips
- 5 discounted opportunities for dividend growth investors
- 3 Stocks Leading the U.S. Agriculture Comeback
- How to Invest in Insurance Companies: A Guide
- How to Use Put Debit Spreads to Profit From Falling Stocks
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Alphabet Changes the Narrative with Its First-Ever Dividend
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.